[PDF][PDF] Pharmacogenetics and chronic pain management
… CYP2D6 genotyping revealed that the infant’s mother was … in pain management include
amitriptyline and imipramine (… demonstrated effectiveness in the treatment of diabetic neuropathy…
amitriptyline and imipramine (… demonstrated effectiveness in the treatment of diabetic neuropathy…
The future of pharmacogenetics in the treatment of migraine
M Borro, M Guglielmetti, M Simmaco… - …, 2019 - Future Medicine
… active effects of the drug resulting potentially in increased efficacy but … CYP2D6 and CYP2C19
defective variants and increased risk of side effects in patients treated with amitriptyline [96…
defective variants and increased risk of side effects in patients treated with amitriptyline [96…
[HTML][HTML] Pharmacogenetic testing for the pediatric gastroenterologist: Actionable drug–gene pairs to know
T Sandritter, R Chevalier, R Abt, V Shakhnovich - Pharmaceuticals, 2023 - mdpi.com
… physiologic effects of the medication in the body (ie, efficacy, … effects: some studies find patients
with the rs6311 genotype C/C … amitriptyline and nortriptyline are hydroxylated by CYP2D6 …
with the rs6311 genotype C/C … amitriptyline and nortriptyline are hydroxylated by CYP2D6 …
Phenotypes and genotypes in postherpetic neuralgia drug therapy: a narrative mini-review
… (nortriptyline and amitriptyline) and anticonvulsants (… For instance, the CYP2D6 genotype
was reported by Nasare … association study for the efficacy of drugs for the treatment of …
was reported by Nasare … association study for the efficacy of drugs for the treatment of …
Individualizing analgesic prescription. Part II: pharmacogenetics of anti-inflammatory analgesics and co-analgesics
CF Samer, JA Desmeules, P Dayer - 2006 - Taylor & Francis
… is associated with a lower clearance of amitriptyline (Figure 7) , … the impact of the SERTPR
genotype on the efficacy and safety of … CYP2D6 genotype had no impact on the safety and …
genotype on the efficacy and safety of … CYP2D6 genotype had no impact on the safety and …
Progress and prospects in pharmacogenetics of antidepressant drugs
C Fabbri, C Crisafulli, M Calabrò, E Spina… - Expert Opinion on …, 2016 - Taylor & Francis
… detrimental effect of the S allele on antidepressant efficacy … The most replicated association
was between CYP2D6 … only in patients treated with P-gp substrates (amitriptyline, citalopram, …
was between CYP2D6 … only in patients treated with P-gp substrates (amitriptyline, citalopram, …
The clinical application of pharmacogenetics in understanding drug response
PS Kee - 2023 - ourarchive.otago.ac.nz
… The candidate carried out genotyping and haplotyping (~60 … In order to predict the clinical
utility of CYP2D6 and CYP2C19 … SNP exerting their effects through unknown mechanisms …
utility of CYP2D6 and CYP2C19 … SNP exerting their effects through unknown mechanisms …
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?
D Seripa, M Lozupone, E Stella, G Paroni… - Expert Opinion on …, 2017 - Taylor & Francis
… citalopram [Citation64], and amitriptyline [Citation65]. CYP3A … , PMs CYP2D6 genotype
predicted the risk of adverse effects … in drug metabolism, therapeutic efficacy, and drug-induced …
predicted the risk of adverse effects … in drug metabolism, therapeutic efficacy, and drug-induced …
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial
EML Smith, H Pang, C Cirrincione, S Fleishman… - Jama, 2013 - jamanetwork.com
… Other factors to consider when judging clinical significance include how quickly the drug
takes effect, tolerability, and the drug's influence on other efficacy end points such as function …
takes effect, tolerability, and the drug's influence on other efficacy end points such as function …
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study
YH Yang, JK Lin, WS Chen, TC Lin, SH Yang… - Supportive Care in …, 2012 - Springer
… This open-label pilot study is aimed to evaluate the efficacy … 30 patients with oxaliplatin-induced
peripheral neuropathy … in our study was consistent with its effect in the treatment of DPNP…
peripheral neuropathy … in our study was consistent with its effect in the treatment of DPNP…